News Releases

Earle Chambers, Ph.D., M.P.H., Appointed Director of Research in Department of Family and Social Medicine at Einstein and Montefiore
NIH Awards $9.5 Million for Einstein-Mount Sinai Diabetes Research Center
A Common Blood Test Identifies Which COVID-19 Patients Benefit and Which Are Harmed from Steroid Treatment

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Mario J. Garcia

Mario J. Garcia, M.D.

Area(s) of expertise: Heart DiseaseCardiologyCardiac imaging

Dr. Garcia is a physician, researcher and educator known for his innovative use of noninvasive cardiac imaging in… Learn more

Einstein in the News

Hospital CEO Says We Are Battling 2 Viruses: Coronavirus and Racism

Philip Ozuah, M.D., Ph.D., recounts painful personal experiences of racism, addresses how the COVID-19 pandemic disproportionately hurt minorities, and shares his hopes for societal change. Dr. Ozuah is president and CEO of Montefiore Medicine.

Additional Coverage includes US News & World Report, The New York Times, MSNBC

More coverage on Dr. Ozuah

Los Angeles Times
How Scientists Revived an Old-School Treatment for a 21st Century Pandemic

Liise-anne Pirofski, M.D., discusses the use of plasma from people who have recovered from COVID-19 to potentially prevent and treat the disease. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.

Additional Coverage includes The Lancet, CNN, USA Today, Nature, The Atlantic, Wall Street Journal (subscription required ), Associated Press, NPR, LA Times, NBC News, CBS News

More coverage on this storyMore coverage on Dr. Pirofski

Gut Microbes and Stress Team Up to Make a Painful Disease Worse

Paul Frenette, M.D., has led and published research showing that the gut microbiome and stress play a role in triggering painful vessel-clogging episodes in sickle-cell disease. Dr. Frenette is professor of medicine and of cell biology, and chair and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.

More coverage on Dr. Frenette


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog